Study provides additional evidence to expand access to living-donor liver transplant for all children in need
AURORA, Colo., Nov. 20, 2026 /PRNewswire/ — Infants diagnosed with biliary atresia who receive a living-donor liver transplant (LDLT) have lower overall healthcare costs than those who receive a deceased-donor liver transplant (DDLT), demonstrated by a new research study led by Amy Feldman, MD, PhD, Medical Director of the Liver Transplant Program at Children’s Hospital Colorado (Children’s Colorado). This study adds to well-established evidence that LDLTs can reduce waitlist times and improve outcomes for children, supporting the need for insurance coverage for LDLT nationwide.
The study used two national datasets, the Pediatric Health Information System and the Scientific Registry of Transplant Recipients, to compare hospitalization costs between infants with biliary atresia – the leading indication for pediatric liver transplant – who received a LDLT versus a DDLT during the pre-transplant, transplant and one-year post-transplant time periods. The study revealed hospitalization costs were, on average, $45,000 less expensive for LDLT recipients than DDLT recipients. Additionally, the study demonstrated that LDLT recipients required significantly less IV nutrition prior to transplant and significantly less dialysis during transplant, two expensive medical interventions.
“We know living-donor liver transplant decreases waitlist times, reduces morbidity and mortality on the waitlist and leads to improved post-transplant outcomes. Now, we’re proud to fill this critical gap in knowledge that living-donor liver transplant is also less expensive and uses fewer healthcare resources,” said Feldman, who is also an associate professor in the Section of Pediatric Gastroenterology, Hepatology and Nutrition at the University of Colorado School of Medicine. “We hope this research will drive broader policy changes, improve insurance coverage for LDLT and increase access to LDLT for children across the country.”
Expanding access to LDLT is especially urgent for the youngest patients. Infants less than 1 year old have the highest waitlist mortality among all age groups, with approximately one in 10 dying before an organ becomes available. Additionally, research shows access to LDLT can vary significantly based on geography, insurance coverage and whether the child’s home transplant center offers LDLT. Nationally, children who are white or privately insured are more likely to receive a LDLT than Black, Hispanic or publicly insured children.
“No child should die on the waitlist because they only have deceased-donor liver transplant available to them,” Feldman said. “Our goal is for all children to have access to living-donor liver transplant so they can get transplanted as quickly as possible.”
Multi-listing at a center that offers LDLT is one way to ensure children have access to LDLT regardless of where they live and can help prevent deaths on the waitlist nationwide. Children’s Colorado has the highest volume pediatric LDLT program in the country. This has helped bring Children’s Colorado’s average liver transplant waitlist time down to just one-and-a-half months, well below the national average of four months. Even when a child does not have a directed living donor – someone who donates to a specific recipient – there are opportunities for patients to receive a piece of liver from a non-directed donor, someone who donates without knowing the recipient. In partnership with UCHealth University of Colorado Hospital, liver donations from non-directed donors are offered first to children on the Children’s Colorado waitlist. In addition, the adult living donor’s surgery is often done robotically – reducing hospitalization and recovery time – and the liver regenerates to full size in both the donor and recipient in just a few weeks.
ABOUT CHILDREN’S HOSPITAL COLORADO
Children’s Hospital Colorado is one of the nation’s leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and ranked among the best children’s hospitals in the nation as recognized by U.S. News & World Report, Children’s Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children’s Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region. For more information, visit www.childrenscolorado.org or connect with us on Facebook, Instagram and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-childrens-hospital-colorado-research-highlights-financial-benefits-of-living-donor-liver-transplant-302947144.html
SOURCE Children’s Hospital Colorado
